{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:43:06Z","timestamp":1792057386474,"version":"4.4.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2020.3711","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:32:34Z","timestamp":1587555154000},"page":"e203711","source":"Crossref","is-referenced-by-count":269,"title":["Association of Racial\/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States"],"prefix":"10.1001","volume":"3","author":[{"given":"William C.","family":"Goedel","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Cerd\u00e1","sequence":"additional","affiliation":[{"name":"Department of Population Health, New York University School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer W.","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Hadland","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Boston University School of Medicine, Boston, Massachusetts"},{"name":"Grayken Center for Addiction Medicine, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D. L.","family":"Marshall","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"issue":"50-51","key":"zoi200173r1","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000-2014.","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50-51","key":"zoi200173r2","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010-2015.","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5152","key":"zoi200173r3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths\u2014United States, 2013-2017.","volume":"67","author":"Scholl","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"zoi200173r4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7621","article-title":"Prevention of prescription opioid misuse and projected overdose deaths in the United States.","volume":"2","author":"Chen","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"zoi200173r6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"key":"zoi200173r7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.drugalcdep.2018.09.020","article-title":"Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012-2014.","volume":"194","author":"Chatterjee","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"10182","key":"zoi200173r8","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/S0140-6736(18)33078-2","article-title":"Management of opioid use disorder in the USA: present status and future directions.","volume":"393","author":"Blanco","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"zoi200173r9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder.","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"zoi200173r10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/add.v111.4","article-title":"Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial.","volume":"111","author":"Hser","year":"2016","journal-title":"Addiction"},{"issue":"8","key":"zoi200173r11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1001\/jama.1965.03090080008002","article-title":"A medical treatment for diacetylmorphine (heroin) addiction: a clinical trial with methadone hydrochloride.","volume":"193","author":"Dole","year":"1965","journal-title":"JAMA"},{"issue":"4","key":"zoi200173r12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/archinte.1966.00290160004002","article-title":"Narcotic blockade: a medical technique for stopping heroin use by addicts.","volume":"118","author":"Dole","year":"1966","journal-title":"Arch Intern Med"},{"issue":"12","key":"zoi200173r13","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1001\/jama.1968.03150120042009","article-title":"Successful treatment of 750 criminal addicts.","volume":"206","author":"Dole","year":"1968","journal-title":"JAMA"},{"issue":"6","key":"zoi200173r16","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1001\/jama.1974.03230310035024","article-title":"Methadone and chemotherapy in drug addiction: genocidal or lifesaving?","volume":"228","author":"Chappel","year":"1974","journal-title":"JAMA"},{"issue":"6","key":"zoi200173r17","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1177\/1049732311432718","article-title":"Methadone as social control: institutionalized stigma and the prospect of recovery.","volume":"22","author":"Harris","year":"2012","journal-title":"Qual Health Res"},{"issue":"1","key":"zoi200173r18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/clpt.1988.13","article-title":"A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.","volume":"43","author":"Bickel","year":"1988","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"zoi200173r20","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2105\/AJPH.2016.303483","article-title":"Is the prescription opioid epidemic a white problem?","volume":"106","author":"Hansen","year":"2016","journal-title":"Am J Public Health"},{"issue":"3","key":"zoi200173r22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City.","volume":"40","author":"Hansen","year":"2013","journal-title":"J Behav Health Serv Res"},{"issue":"6","key":"zoi200173r26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.annepidem.2006.10.015","article-title":"Positional accuracy and geographic bias of four methods of geocoding in epidemiologic research.","volume":"17","author":"Schootman","year":"2007","journal-title":"Ann Epidemiol"},{"issue":"2","key":"zoi200173r29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.2517-6161.1948.tb00012.x","article-title":"The interpretation of statistical maps.","volume":"10","author":"Moran","year":"1948","journal-title":"J R Stat Soc Series B Stat Methodol"},{"issue":"3","key":"zoi200173r30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/gean.1972.4.issue-3","article-title":"Testing for spatial autocorrelation among regression residuals.","volume":"4","author":"Cliff","year":"1972","journal-title":"Geogr Anal"},{"issue":"4","key":"zoi200173r32","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s11013-016-9496-5","article-title":"The War on Drugs that wasn\u2019t: wasted whiteness, \u201cdirty doctors,\u201d and race in media coverage of prescription opioid misuse.","volume":"40","author":"Netherland","year":"2016","journal-title":"Cult Med Psychiatry"},{"key":"zoi200173r33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugalcdep.2015.12.035","article-title":"Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration.","volume":"160","author":"Manhapra","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"zoi200173r34","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1001\/jama.288.7.850","article-title":"Changes in methadone treatment practices: results from a national panel study, 1988-2000.","volume":"288","author":"D\u2019Aunno","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"zoi200173r37","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s11606-018-4801-3","article-title":"Methadone matters: what the United States can learn from the global effort to treat opioid addiction.","volume":"34","author":"Calcaterra","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"4","key":"zoi200173r38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/08897077.2018.1449166","article-title":"A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees.","volume":"39","author":"Stein","year":"2018","journal-title":"Subst Abus"},{"issue":"5","key":"zoi200173r40","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11920-007-0046-2","article-title":"Why buprenorphine is so successful in treating opiate addiction in France.","volume":"9","author":"Fatseas","year":"2007","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"zoi200173r41","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jrh.2019.35.issue-1","article-title":"Geographic distribution of providers with a DEA waiver to prescribe buprenorphine for the treatment of opioid use disorder: A 5-year update.","volume":"35","author":"Andrilla","year":"2019","journal-title":"J Rural Health"},{"issue":"3","key":"zoi200173r42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamapsychiatry.2018.3685","article-title":"Buprenorphine deregulation and mainstreaming treatment for opioid use disorder: X the X waiver.","volume":"76","author":"Fiscella","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"zoi200173r43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1177\/1077558711420263","article-title":"Residential segregation and disparities in health care services utilization.","volume":"69","author":"Gaskin","year":"2012","journal-title":"Med Care Res Rev"},{"issue":"6","key":"zoi200173r44","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders.","volume":"19","author":"Sharma","year":"2017","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"zoi200173r45","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1081\/ADA-100101886","article-title":"Changes in methadone treatment practices: results from a panel study, 1988-1995.","volume":"25","author":"D\u2019Aunno","year":"1999","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"7","key":"zoi200173r46","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1068\/a231025","article-title":"The modifiable areal unit problem in multivariate statistical analyses.","volume":"23","author":"Fotheringham","year":"1991","journal-title":"Environ Plan"},{"key":"zoi200173r5","volume-title":"National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","author":"American Society of Addiction Medicine","year":"2015"},{"key":"zoi200173r14","first-page":"120","volume-title":"Federal Regulation of Methadone Treatment","author":"Institute of Medicine Committee on Federal Regulation of Methadone Treatment","year":"1995"},{"key":"zoi200173r15","volume-title":"Federal Guidelines for Opioid Treatment Programs","author":"Substance Abuse and Mental Health Services Administration","year":"2015"},{"key":"zoi200173r19"},{"key":"zoi200173r21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1108\/S1057-6290(2012)0000014008","volume-title":"Critical Perspectives on Addiction","author":"Hansen","year":"2012"},{"key":"zoi200173r23","volume-title":"Racial and Ethnic Residential Segregation in the United States: 1980-2000","author":"Iceland","year":"2002"},{"key":"zoi200173r28","volume-title":"2013 NCHS Urban\u2013Rural Classification Scheme for Counties","author":"National Center for Health Statistics","year":"2014"},{"key":"zoi200173r31","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4135\/9780857020130.n14","volume-title":"The SAGE Handbook of Spatial Analysis","author":"Anselin","year":"2009"},{"key":"zoi200173r35","volume-title":"The SAMHSA Evaluation of the Impact of the DATA Waiver Program, Summary Report","author":"Stanton","year":"2006"},{"key":"zoi200173r36","volume-title":"Trends in the Use of Methadone, Buprenorphine, and Extended-release Naltrexone at Substance Abuse Treatment Facilities: 2003-2015 (Update)","author":"Alderks","year":"2017"},{"key":"zoi200173r39"},{"key":"zoi200173r24","unstructured":"Substance Abuse and Mental Health Services Administration. Opioid treatment program directory. Accessed February 6, 2020. https:\/\/dpt2.samhsa.gov\/treatment\/"},{"key":"zoi200173r25","unstructured":"Substance Abuse and Mental Health Services Administration. Buprenorphine practitioner locator. Accessed February 6, 2020. https:\/\/www.samhsa.gov\/medication-assisted-treatment\/practitioner-program-data\/treatment-practitioner-locator"},{"key":"zoi200173r27","unstructured":"National Center for Health Statistics. Wide-Ranging Online Database for Epidemiologic Research (WONDER). Accessed February 6, 2020. https:\/\/wonder.cdc.gov\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2764663\/goedel_2020_oi_200173_1645472503.68255.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T08:59:03Z","timestamp":1722761943000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2764663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3711","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]}}}